This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2026 — Pharmaceutical Compliance Congress
April 27-29, 2026
The Ritz-Carlton, Tysons Corner | McLean, VA
View Team PricingBook Now
Menu
Book
View Team Pricing
Key Sessions
Lisa LeCointe-Cephas
Chairperson's Opening Remarks
Johnson & Johnson Innovative Medicine
Jill Fallows Macaluso
Keynote CCO: Organizational Value of Compliance
Novo Nordisk
keyboard_arrow_right

2026 Day 2 Agenda - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
close
2026 Day 2 Agenda - ET (Eastern Time, GMT-05:00)
close
Showing 1 of 1 Streams
9:30am - 10:10am
Keynote CCO: Organizational Value of Compliance
  • How do you define compliance value?
  • What really matters to the Board, when showcasing the value of Compliance?
  • Translating compliance activities into performance
  • Jill Fallows Macaluso - Corporate Vice President & Chief Compliance Officer, Novo Nordisk
Showing 1 of 1 Streams
11:20am - 12:00pm
Former Prosecutors Panel - Interpreting the Latest DOJ Actions and Investigations
  • Commentary on the latest developments from DOJ
  • Update on DOJ’s health care fraud, FCPA, and other corporate enforcement
  • DOJ guidance to prosecutors and its significance for pharmaceutical companies
  • The current state of False Claims Act litigation
  • Amanda Masselam Strachan - Partner, WilmerHale
Topic Intensives - Delve into the detail with practical scenarios and hands on approaches
Showing 1 of 1 Streams
3:50pm - 4:55pm
Guardrails for Evolving Field Facing Roles
  • How can we ensure we are communicating in every way we can communicate whilst remaining compliant?
  • Interactions with GPOs – examining the types of interactions with field roles, what they can talk about and what can they do
  • Medical commercial interactions: helping Compliance keep pace with agile approaches
  • Considerations when using scientific platforms to engage HCPs
  • Rore Middleton - Vice President, Compliance and Ethics, Blueprint Medicines
  • Peter Agnoletto - Compliance Officer, General Medicines and Consumer Healthcare, Sanofi
  • Alicia Whittlesey - Vice President, Compliance & Regulatory Services, Porzio Life Sciences, LLC
  • Kimberly Gregorio - Vice President, P360
2026 Day 1 Agenda
Next2026 Day 3 Agenda
Filter
Streams
Formats
Choose Day